Test Price
1,400 AED✅ Home Collection Available
Rett Syndrome Deletion & Duplication Detection (MLPA) in UAE | 1400 AED | 2026 DHA Guidelines
تحليل الحذف والتضاعف الجيني لمتلازمة ريت (MLPA) في الإمارات | 1400 درهم | معتمد من هيئة الصحة بدبي
🔬 Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
🚚 Premium Logistics: Paid Hospital-Grade Home Collection – ISO Certified Cold-Chain & VIP Mobile Phlebotomy.
🩺 Clinical Guidance: Telephonic Post-Test Clinical Guidance on result interpretation by DHA-licensed expert.
💳 Insurance: Direct Billing Verification via WhatsApp: +971 54 548 8731.
الملخص التنفيذي
اختبار جيني لتأكيد تشخيص متلازمة ريت (طفرات الحذف والتضاعف في جين MECP2) بحساسية 99.9%، مع سحب منزلي مبرد ومعتمد من الهيئات الصحية. يتوفر دعم طبي هاتفي بعد النتيجة، وتتم مطابقة التأمين الصحي عبر الواتساب.
🏛️ UAE Healthcare Compliance: Licensed Facility No. 9834453. ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139). Test conducted in strict accordance with Federal Decree-Law No. 41 of 2024 (Art. 87), CDS Law 2026 (Minors), and UAE PDPL. Your data is sovereignty‑protected and never stored outside the UAE.
📋 Test Overview
Rett Syndrome Deletion & Duplication Detection is a high‑resolution genetic test that uses MLPA (Multiplex Ligation‑dependent Probe Amplification) to identify exon‑level copy number changes in the MECP2 gene. This test is the definitive molecular confirmation for Rett syndrome, enabling early, tailored intervention for affected children in the UAE. (يكشف الاختبار بدقة الحذف والتضاعف الجيني المسبب لمتلازمة ريت)
| Feature | Our Test (Apex Medical Lab) | Closest Alternative |
|---|---|---|
| Precision | MLPA – detects single‑exon deletions/duplications | Sequencing – may miss large copy‑number variants |
| Methodology | ISO‑certified MLPA with automated analysis | Research‑grade MLPA or targeted NGS |
| Turnaround | 7–10 days | 10–18 days |
| Home Collection | ✔ Hospital‑grade, cold‑chain, 8 AM–11 PM | Limited or non‑compliant |
👨⚕️ Physician Insight & Safety Protocol
Dr. PRABHAKAR REDDY (DHA License: 61713011) emphasizes: “A positive MLPA result for Rett syndrome must be interpreted alongside clinical findings by a multidisciplinary team. This test confirms the diagnosis, but the child’s developmental trajectory depends on early therapeutic intervention. I urge parents to use this result as a gateway to paediatric neurology and genetic counselling, not as a standalone verdict.”
⚠️ Do not discontinue prescribed medication without consulting your doctor. Genetic findings do not replace ongoing medical management.
🛑 Exclusion Criteria & ER Red Flags
- Active febrile illness requiring immediate hospitalisation (defer elective genetic testing).
- Severe haemodynamic instability or acute respiratory distress — proceed to emergency department.
- Uncontrolled seizure activity in the child (call 998 before scheduling collection).
- A doctor’s prescription is mandatory; exceptions: surgery clearance, pregnancy‑related screening, or international travel requirements (self‑referral accepted).
- Minors (<18 years) must be accompanied by a parent/legal guardian per CDS Law 2026.
❓ Patient FAQ & Clinical Guidance
Q1: Who are the best specialists to review this Rett syndrome genetic test result?
Direct Answer: A Clinical Geneticist, who interprets gene‑specific deletions, together with a Pediatric Neurologist for seizure and motor management, and a Developmental Pediatrician for early intervention planning, forms the ideal tri‑specialist team.
أفضل التخصصات: أخصائي الوراثة السريرية (لفك شيفرة الجين)، وطبيب أعصاب الأطفال (لإدارة التشنجات والحركة)، وطبيب النمو والتطور (للتدخل المبكر). هذا الفريق الثلاثي يضمن التفسير الشامل للنتيجة.
Q2: What does a negative MLPA result for Rett syndrome mean?
Direct Answer: A negative MLPA result means no large deletion or duplication was detected in MECP2, but it does not rule out point mutations or atypical Rett syndromes; further sequencing may still be required.
النتيجة السلبية لا تنفي وجود طفرات نقطية أو متلازمات ريت غير النمطية؛ قد يوصي الطبيب بإجراء تسلسل جيني إضافي لتأكيد التشخيص.
Q3: Is home sample collection safe and reliable for this pediatric genetic?
Direct Answer: Yes, our DHA‑approved phlebotomists use hospital‑grade, cold‑chain transport that preserves DNA integrity, making home collection as reliable as in‑lab draws for MLPA testing.
نعم، فريق السحب المنزلي المعتمد من هيئة الصحة يستخدم حاويات مبردة معتمدة تحفظ الحمض النووي، مما يجعل دقة النتيجة مطابقة تمامًا للسحب في المختبر.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians